These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36476249)

  • 1. Mortality risk prediction with ILD-GAP index in a fibrotic hypersensitivity pneumonitis cohort.
    Mendonça Almeida L; Fernandes AL; Gouveia Cardoso C; Lima B; Neves I; Novais-Bastos H; Caetano Mota P; Melo N; Souto Moura C; Guimarães S; Carvalho A; Cunha R; Pereira JM; Morais A
    Ther Adv Respir Dis; 2022; 16():17534666221135316. PubMed ID: 36476249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting survival across chronic interstitial lung disease: the ILD-GAP model.
    Ryerson CJ; Vittinghoff E; Ley B; Lee JS; Mooney JJ; Jones KD; Elicker BM; Wolters PJ; Koth LL; King TE; Collard HR
    Chest; 2014 Apr; 145(4):723-728. PubMed ID: 24114524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial changes of CT findings in patients with chronic hypersensitivity pneumonitis: imaging trajectories and predictors of fibrotic progression and acute exacerbation.
    Choe J; Chae EJ; Kim YJ; Do KH; Song JS; Song JW
    Eur Radiol; 2021 Jun; 31(6):3993-4003. PubMed ID: 33241510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated computer-based CT stratification as a predictor of outcome in hypersensitivity pneumonitis.
    Jacob J; Bartholmai BJ; Rajagopalan S; Karwoski R; Mak SM; Mok W; Della Casa G; Sugino K; Walsh SLF; Wells AU; Hansell DM
    Eur Radiol; 2017 Sep; 27(9):3635-3646. PubMed ID: 28130610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute exacerbations of fibrotic interstitial lung diseases.
    Suzuki A; Kondoh Y; Brown KK; Johkoh T; Kataoka K; Fukuoka J; Kimura T; Matsuda T; Yokoyama T; Fukihara J; Ando M; Tanaka T; Hashimoto N; Sakamoto K; Hasegawa Y
    Respirology; 2020 May; 25(5):525-534. PubMed ID: 31426125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mosaic attenuation in non-fibrotic areas as a predictor of non-usual interstitial pneumonia pathologic diagnosis.
    Gayá García-Manso I; Arenas-Jiménez J; García-Sevila R; Ruiz-Alcaraz S; Sirera-Matilla M; García-Garrigós E; Martínez-García MÁ; Hernández-Blasco L
    Sci Rep; 2022 May; 12(1):7289. PubMed ID: 35508493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.
    Yıldırım F; Türk M; Bitik B; Erbaş G; Köktürk N; Haznedaroğlu Ş; Türktaş H
    Kaohsiung J Med Sci; 2019 Jun; 35(6):365-372. PubMed ID: 30913371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Derivation and validation of a prediction model for histopathologic fibrotic hypersensitivity pneumonitis.
    De Giacomi F; White D; Decker PA; Vaszar LT; Sandbo N; Lee AS; Ryu JH; Moua T
    Respir Med; 2021 Oct; 187():106598. PubMed ID: 34481307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in interstitial lung disease associated with primary Sjögren's syndrome: a retrospective analysis of 33 pathologically-proven cases.
    Enomoto Y; Takemura T; Hagiwara E; Iwasawa T; Fukuda Y; Yanagawa N; Sakai F; Baba T; Nagaoka S; Ogura T
    PLoS One; 2013; 8(9):e73774. PubMed ID: 24040065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of interstitial lung disease and mortality in rheumatoid arthritis.
    Zamora-Legoff JA; Krause ML; Crowson CS; Ryu JH; Matteson EL
    Rheumatology (Oxford); 2017 Mar; 56(3):344-350. PubMed ID: 27940586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute exacerbation of fibrotic hypersensitivity pneumonitis: incidence and outcomes.
    Kang J; Kim YJ; Choe J; Chae EJ; Song JW
    Respir Res; 2021 May; 22(1):152. PubMed ID: 34016104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative CT and machine learning classification of fibrotic interstitial lung diseases.
    Koo CW; Williams JM; Liu G; Panda A; Patel PP; Frota Lima LMM; Karwoski RA; Moua T; Larson NB; Bratt A
    Eur Radiol; 2022 Dec; 32(12):8152-8161. PubMed ID: 35678861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep Learning-based Outcome Prediction in Progressive Fibrotic Lung Disease Using High-Resolution Computed Tomography.
    Walsh SLF; Mackintosh JA; Calandriello L; Silva M; Sverzellati N; Larici AR; Humphries SM; Lynch DA; Jo HE; Glaspole I; Grainge C; Goh N; Hopkins PMA; Moodley Y; Reynolds PN; Zappala C; Keir G; Cooper WA; Mahar AM; Ellis S; Wells AU; Corte TJ
    Am J Respir Crit Care Med; 2022 Oct; 206(7):883-891. PubMed ID: 35696341
    [No Abstract]   [Full Text] [Related]  

  • 14. Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD).
    Solomon JJ; Ryu JH; Tazelaar HD; Myers JL; Tuder R; Cool CD; Curran-Everett D; Fischer A; Swigris JJ; Brown KK
    Respir Med; 2013 Aug; 107(8):1247-52. PubMed ID: 23791462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: clinical features and prognosis.
    Izuka S; Yamashita H; Iba A; Takahashi Y; Kaneko H
    Rheumatology (Oxford); 2021 May; 60(5):2348-2354. PubMed ID: 33241299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease.
    Wong AW; Lee TY; Johannson KA; Assayag D; Morisset J; Fell CD; Fisher JH; Shapera S; Gershon AS; Cox G; Halayko AJ; Hambly N; Manganas H; Sadatsafavi M; Wilcox PG; To T; Marcoux V; Khalil N; Kolb M; Ryerson CJ
    Respir Res; 2020 Dec; 21(1):322. PubMed ID: 33287805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of BMI and Change in Weight With Mortality in Patients With Fibrotic Interstitial Lung Disease.
    Comes A; Wong AW; Fisher JH; Morisset J; Johannson KA; Farrand E; Fell CD; Kolb M; Manganas H; Cox G; Gershon AS; Halayko AJ; Hambly N; Khalil N; Sadatsafavi M; Shapera S; To T; Wilcox PG; Collard HR; Ryerson CJ
    Chest; 2022 May; 161(5):1320-1329. PubMed ID: 34788669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease.
    Morisset J; Vittinghoff E; Lee BY; Tonelli R; Hu X; Elicker BM; Ryu JH; Jones KD; Cerri S; Manfredi A; Sebastiani M; Gross AJ; Ley B; Wolters PJ; King TE; Kim DS; Collard HR; Lee JS
    Respir Med; 2017 Jun; 127():51-56. PubMed ID: 28502419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of cytotoxic chemotherapy-related exacerbation of interstitial lung disease with lung cancer.
    Kenmotsu H; Naito T; Kimura M; Ono A; Shukuya T; Nakamura Y; Tsuya A; Kaira K; Murakami H; Takahashi T; Endo M; Yamamoto N
    J Thorac Oncol; 2011 Jul; 6(7):1242-6. PubMed ID: 21623239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the ILD-GAP Model and a Local Nomogram in a Singaporean Cohort.
    Kam MLW; Li HH; Tan YH; Low SY
    Respiration; 2019; 98(5):383-390. PubMed ID: 31578022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.